Single-use Bioprocessing Systems Market - Size, Share, and Forecast, 2022 - 2028

Single-use Bioprocessing Systems Market - Size, Share, and Forecast, 2022 - 2028

Report Description
Single-use bioprocessing system is majorly used in the upstream and downstream bioprocessing method. Moreover, key advantages offered by single-use bioprocessing such as cost reduction, increased productivity, low energy and water consumption during bioprocessing, easy disposable and reduced risk of cross contamination allows its easy and increased adoption over conventional bioprocessing systems. Moreover, government regulatory organizations are majorly adopting single-use bioprocessing systems, owing to its advantges. For instance, Australian Government: Therapeutic Goods Administration (TGA) allows the use of single-use systems in buffer preparation, mixing, and other upstream processing. Apart from this, TGA also proposed GMP regulation for filters, equipment used in single-use systems. Furthermore, increasing demand of biopharmaceuticals, growing investment on research and development activities and increasing number of key players offering affordable and technologically advanced disposable bioprocessing products are projected to drive growth of the single-use bioprocessing systems market over the forecast period.
Market Dynamics
The global single-use bioprocessing systems market is projected to witness significant growth over the forecast period, owing to its wide applications in production of monoclonal antibodies, vaccine production, and therapeutic drugs. Moreover, key players in the market are engaged in organic and in-organic growth strategies such as collaborations, strategic agreement, partnerships, mergers and acquisitions to retain competitive position in market. For instance, in April 2018, Saint-Gobain acquired the pharmaceutical business of Micro Hydraulics to strengthen its high performance material portfolio with the addition of single-use fluid handling components and systems. In August 2016, Saint-Gobain acquired Twin Bay Medical, which has added flexible tube retainers and single-use component portfolio of Twin Bay Medical into Saint-Gobain’s portfolio. In February 2015, Thermo Fisher Scientific acquired Advanced Scientifics, Inc., the provider of single-use technologies for customized bioprocessing solutions for deal value of US$ 300 million in cash. Furthermore, in November 2021, General Electric Company acquired Puridify, a bioprocessing start-up company. These acquisition help to add a nanofiber-based platform purification technology to GE Healthcare’s product portfolio. These mergers and acquisitions are expected to bring innovative single use bioprocessing systems during the forecast period.
Key features of the study:
This report provides in-depth analysis of the single-use bioprocessing systems market and its market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global single-use bioprocessing systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Parker-Hannifin Corporation, Sartorius AG, Eppendorf AG, Danaher Corporation, Merck KGaA, and General Electric Company.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
The global single-use bioprocessing systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for single-use bioprocessing systems market, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:
Global Single-use Bioprocessing Systems Market, By Product Type:
Instruments
Accessories
Global Single-use Bioprocessing Systems Market, By Application:
Monoclonal Antibody Production
Vaccine Production
Patient Specific Cell Therapies
Other Applications
Global Single-use Bioprocessing Systems Market, By End User:
Biotechnology and Pharmaceutical Companies
Research & Academic Research Institutes
Contract Research Organizations(CRO) & Contract Manufacturing Organizations(CMO)
Global Single-use Bioprocessing Systems Market, By Region:
North America Single-use Bioprocessing Systems Market
By Country:
U.S.
Canada
By Product Type:
Instruments
Accessories
By Application:
Monoclonal Antibody Production
Vaccine Production
Patient Specific Cell Therapies
Other Applications
By End User:
Biotechnology and Pharmaceutical Companies
Research & Academic Research Institutes
Contract Research Organizations( CRO) & Contract Manufacturing Organizations (CMO)
Europe Single-use Bioprocessing Systems Market
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Instruments
Accessories
By Application:
Monoclonal Antibody Production
Vaccine Production
Patient Specific Cell Therapies
Other Applications
By End User:
Biotechnology and Pharmaceutical Companies
Research & Academic Research Institutes
Contract Research Organizations (CRO) & Contract Manufacturing Organizations (CMO)
Asia Pacific Single-use Bioprocessing Systems Market
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
By Product Type:
Instruments
Accessories
By Application:
Monoclonal Antibody Production
Vaccine Production
Patient Specific Cell Therapies
Other Applications
By End User:
Biotechnology and Pharmaceutical Companies
Research & Academic Research Institutes
Contract Research Organizations (CRO) & Contract Manufacturing Organizations (CMO)
Latin America Single-use Bioprocessing Systems Market
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Instruments
Accessories
By Application:
Monoclonal Antibody Production
Vaccine Production
Patient Specific Cell Therapies
Other Applications
By End User:
Biotechnology and Pharmaceutical Companies
Research & Academic Research Institutes
Contract Research Organizations (CRO) & Contract Manufacturing Organizations (CMO)
Middle East Single-use Bioprocessing Systems Market
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Instruments
Accessories
By Application:
Monoclonal Antibody Production
Vaccine Production
Patient Specific Cell Therapies
Other Applications
By End User:
Biotechnology and Pharmaceutical Companies
Research & Academic Research Institutes
Contract Research Organizations (CRO) & Contract Manufacturing Organizations (CMO)
Africa Single-use Bioprocessing Systems Market
By Country:
North Africa
Central Africa
South Africa
By Product Type:
Instruments
Accessories
By Application:
Monoclonal Antibody Production
Vaccine Production
Patient Specific Cell Therapies
Other Applications
By End User:
Biotechnology and Pharmaceutical Companies
Research & Academic Research Institutes
Contract Research Organizations (CRO) & Contract Manufacturing Organizations (CMO)
Company Profiles
Compagnie de Saint-Gobain S.A. *
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Thermo Fisher Scientific Inc.
Applikon Biotechnology BV
Parker-Hannifin Corporation
Sartorius AG
Eppendorf AG
Danaher Corporation
Merck KGaA
General Electric Company
“*” marked represents similar segmentation in other categories in the respective section.